Zobrazeno 1 - 10
of 232
pro vyhledávání: '"Lloyd RL"'
Autor:
Hjelle R; Department of Psychology, University of Minnesota, 1207 Ordean Court, Duluth, MN 55812, USA. Electronic address: hjell012@d.umn.edu., Lloyd RL; Department of Psychology, University of Minnesota, 1207 Ordean Court, Duluth, MN 55812, USA., Gunther G; Department of Psychology, University of Minnesota, 1207 Ordean Court, Duluth, MN 55812, USA., Schumacher M; Department of Psychology, University of Minnesota, 1207 Ordean Court, Duluth, MN 55812, USA.
Publikováno v:
Physiology & behavior [Physiol Behav] 2024 Jun 01; Vol. 280, pp. 114535. Date of Electronic Publication: 2024 Apr 12.
Autor:
Hunter MR; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Cambridge, CB21 6GH, UK., Cui L; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Cambridge, CB21 6GH, UK., Porebski BT; Protein and Nucleic Acid Chemistry, MRC Laboratory of Molecular Biology, Cambridge, CB2 0QH, UK., Pereira S; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Cambridge, CB21 6GH, UK., Sonzini S; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Cambridge, CB21 6GH, UK., Odunze U; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Cambridge, CB21 6GH, UK., Iyer P; Molecular AI, Discovery Sciences, R&D, Astrazeneca, Gothenburg, 431 50, Sweden., Engkvist O; Molecular AI, Discovery Sciences, R&D, Astrazeneca, Gothenburg, 431 50, Sweden., Lloyd RL; Functional Genomics, Discovery Sciences, R&D, AstraZeneca, Cambridge, CB4 0WG, UK., Peel S; Functional Genomics, Discovery Sciences, R&D, AstraZeneca, Cambridge, CB4 0WG, UK., Sabirsh A; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Gothenburg, 431 50, Sweden., Ross-Thriepland D; Functional Genomics, Discovery Sciences, R&D, AstraZeneca, Cambridge, CB4 0WG, UK., Jones AT; Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, CF10 3NB, UK., Desai AS; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Cambridge, CB21 6GH, UK.
Publikováno v:
Small methods [Small Methods] 2023 Sep; Vol. 7 (9), pp. e2201695. Date of Electronic Publication: 2023 Jun 14.
Autor:
Lloyd RL; Wellcome/Cancer Research UK Gurdon Institute, and Department of Biochemistry, University of Cambridge, UK., Urban V; Bioscience, Oncology R&D, AstraZeneca, Cambridge, UK., Muñoz-Martínez F; Wellcome/Cancer Research UK Gurdon Institute, and Department of Biochemistry, University of Cambridge, UK., Ayestaran I; Wellcome/Cancer Research UK Gurdon Institute, and Department of Biochemistry, University of Cambridge, UK., Thomas JC; Wellcome/Cancer Research UK Gurdon Institute, and Department of Biochemistry, University of Cambridge, UK., de Renty C; Bioscience, Oncology R&D, AstraZeneca, Cambridge, UK., O'Connor MJ; Bioscience, Oncology R&D, AstraZeneca, Cambridge, UK., Forment JV; Bioscience, Oncology R&D, AstraZeneca, Cambridge, UK., Galanty Y; Wellcome/Cancer Research UK Gurdon Institute, and Department of Biochemistry, University of Cambridge, UK., Jackson SP; Wellcome/Cancer Research UK Gurdon Institute, and Department of Biochemistry, University of Cambridge, UK.
Publikováno v:
Nucleic acids research [Nucleic Acids Res] 2021 Sep 07; Vol. 49 (15), pp. 8665-8683.
Autor:
Gill SJ; Oncology Safety, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, United Kingdom., Wijnhoven PWG; Bioscience, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Fok JHL; Bioscience, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Lloyd RL; Bioscience, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Cairns J; Discovery Sciences, R&D, AstraZeneca, Cambridge, United Kingdom., Armenia J; Bioinformatics and Data Science, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Nikkilä J; Bioscience, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Lau A; Bioscience, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Bakkenist CJ; Hillman Cancer Center 2.6, Pittsburgh, Pennsylvania., Galbraith SM; Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Vens C; Department of Radiation Oncology, Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands., O'Connor MJ; Oncology R&D, AstraZeneca, Cambridge, United Kingdom. mark.j.oconnor@astrazeneca.com.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2021 Sep; Vol. 20 (9), pp. 1614-1626. Date of Electronic Publication: 2021 Jun 22.
Autor:
Kong, Weiwen1 (AUTHOR), Wei, Yuning1 (AUTHOR), Dong, Zirong1 (AUTHOR), Liu, Wenjuan1 (AUTHOR), Zhao, Jiaxin1 (AUTHOR), Huang, Yan2,3 (AUTHOR), Yang, Jinlong1 (AUTHOR), Wu, Wei1 (AUTHOR), He, Haisheng1 (AUTHOR) he_haisheng@fudan.edu.cn, Qi, Jianping1 (AUTHOR) qijianping@fudan.edu.cn
Publikováno v:
Journal of Nanobiotechnology. 9/11/2024, Vol. 22 Issue 1, p1-16. 16p.
Autor:
Papp, Orsolya1 (AUTHOR), Jordán, Viktória1 (AUTHOR), Hetey, Szabolcs1 (AUTHOR), Balázs, Róbert1 (AUTHOR), Kaszás, Valér1 (AUTHOR), Bartha, Árpád1 (AUTHOR), Ordasi, Nóra N.1 (AUTHOR), Kamp, Sebestyén1 (AUTHOR), Farkas, Bálint1 (AUTHOR), Mettetal, Jerome2 (AUTHOR), Dry, Jonathan R.3 (AUTHOR), Young, Duncan4 (AUTHOR), Sidders, Ben5 (AUTHOR), Bulusu, Krishna C.5 (AUTHOR), Veres, Daniel V.1 (AUTHOR) daniel.veres@turbine.ai
Publikováno v:
NPJ Systems Biology & Applications. 8/8/2024, Vol. 10 Issue 1, p1-15. 15p.
Autor:
Lloyd RL; Bioscience, Oncology R&D, AstraZeneca, Cambridge, UK.; The Wellcome trust and CRUK Gurdon Institute, and Department of Biochemistry, University of Cambridge, Cambridge, UK., Wijnhoven PWG; Bioscience, Oncology R&D, AstraZeneca, Cambridge, UK., Ramos-Montoya A; Bioscience, Oncology R&D, AstraZeneca, Cambridge, UK., Wilson Z; Bioscience, Oncology R&D, AstraZeneca, Alderley Park, UK., Illuzzi G; Bioscience, Oncology R&D, AstraZeneca, Cambridge, UK., Falenta K; Bioscience, Oncology R&D, AstraZeneca, Cambridge, UK., Jones GN; Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, UK., James N; Bioscience, Oncology R&D, AstraZeneca, Alderley Park, UK., Chabbert CD; Bioscience, Oncology R&D, AstraZeneca, Cambridge, UK., Stott J; Quantitative Biology, Discovery Science, Oncology R&D, AstraZeneca, Cambridge, UK., Dean E; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK., Lau A; Bioscience, Oncology R&D, AstraZeneca, Cambridge, UK., Young LA; Bioscience, Oncology R&D, AstraZeneca, Cambridge, UK. Lucy.Young@astrazeneca.com.
Publikováno v:
Oncogene [Oncogene] 2020 Jun; Vol. 39 (25), pp. 4869-4883. Date of Electronic Publication: 2020 May 23.
Autor:
Stuart HT; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK; Department of Biochemistry, University of Cambridge, Cambridge, UK., Stirparo GG; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Lohoff T; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK; Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK., Bates LE; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK; Department of Biochemistry, University of Cambridge, Cambridge, UK., Kinoshita M; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Lim CY; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK; Department of Haematology and Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK., Sousa EJ; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Maskalenka K; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK; Department of Biochemistry, University of Cambridge, Cambridge, UK., Radzisheuskaya A; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK; Department of Biochemistry, University of Cambridge, Cambridge, UK., Malcolm AA; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Alves MRP; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Lloyd RL; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK; Department of Biochemistry, University of Cambridge, Cambridge, UK., Nestorowa S; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK; Department of Haematology and Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK., Humphreys P; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Mansfield W; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Reik W; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK; Babraham Institute and Wellcome Sanger Institute, Cambridge, UK., Bertone P; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Nichols J; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK; Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK., Göttgens B; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK; Department of Haematology and Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK., Silva JCR; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK; Department of Biochemistry, University of Cambridge, Cambridge, UK. Electronic address: jcs64@cam.ac.uk.
Publikováno v:
Cell stem cell [Cell Stem Cell] 2019 Sep 05; Vol. 25 (3), pp. 388-406.e8. Date of Electronic Publication: 2019 Aug 15.
Autor:
Vogel, Anne1 (AUTHOR), Haupts, Anna1 (AUTHOR), Kloth, Michael1 (AUTHOR), Roth, Wilfried1 (AUTHOR), Hartmann, Nils1 (AUTHOR) Nils.Hartmann@unimedizin-mainz.de
Publikováno v:
Diagnostic Pathology. 1/6/2024, Vol. 19 Issue 1, p1-11. 11p.
Publikováno v:
hfm (Healthcare Financial Management). Nov2000, Vol. 54 Issue 11, p69-74. 5p.